Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kidney cancer in 2016: RCC - advances in targeted therapeutics and genomics.

× No keyword cloud information.

8 in total

1. Pathologic T3a renal cell carcinoma: a classification in need of further refinement.

Authors: John M DiBianco; Patrick T Gomella; Mark W Ball
Journal: Ann Transl Med Date: 2018-12

2. Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma.

Authors: Qing Zhang; Kang Tian; Jinjing Xu; Haixu Zhang; Liantao Li; Qiang Fu; Dafei Chai; Huizhong Li; Junnian Zheng
Journal: J Immunol Res Date: 2017-12-20 Impact factor: 4.818

3. Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.

Authors: Lei Li; Xi Chen; Lu Hao; Qiuyan Chen; Haosheng Liu; Qing Zhou
Journal: Biosci Rep Date: 2020-07-31 Impact factor: 3.840

4. Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity.

Authors: Hongyan Liu; Shishuo Sun; Gang Wang; Mengmeng Lu; Xiaokang Zhang; Xiaohuan Wei; Xiaoge Gao; Chao Huang; Zhen Li; Junnian Zheng; Qing Zhang
Journal: Front Oncol Date: 2021-04-19 Impact factor: 6.244

5. NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways.

Authors: Bihui Li; Xing Zhang; Qianyao Ren; Li Gao; Jing Tian
Journal: Front Pharmacol Date: 2022-01-10 Impact factor: 5.810

6. miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1.

Authors: Yongpeng Xie; Luyao Chen; Yu Gao; Xin Ma; Weiyang He; Yu Zhang; Fan Zhang; Yang Fan; Liangyou Gu; Pin Li; Xu Zhang; Xin Gou
Journal: Cancer Cell Int Date: 2020-06-10 Impact factor: 5.722

7. The SOD Mimic MnTnHex-2-PyP⁵⁺ Reduces the Viability and Migration of 786-O Human Renal Cancer Cells.

Authors: João G Costa; Nuno Saraiva; Ines Batinic-Haberle; Matilde Castro; Nuno G Oliveira; Ana S Fernandes
Journal: Antioxidants (Basel) Date: 2019-10-17

Review 8. Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma.

Authors: Ieman A M Aljahdali; Renyuan Zhang; Fengzhi Li; Kent L Nastiuk; John J Krolewski; Xiang Ling
Journal: J Exp Clin Cancer Res Date: 2021-08-12

8 in total